PPCB
Propanc Biopharma, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$4.81M
P/E Ratio
0.00
EPS
$570.50
Beta
3.40
52W High
$270.25
52W Low
$1.30
50-Day MA
$2.28
200-Day MA
$18.15
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Propanc Biopharma, Inc. Common Stock
Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. The company is headquartered in Camberwell, Australia.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-18.37M |
| Operating Margin | 0.00% |
| Return on Equity | -127.00% |
| Return on Assets | -62.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $11.24 |
| Price-to-Book | 0.56 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 2.90 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $2.28M |
| Float | $1.63M |
| % Insiders | 14.85% |
| % Institutions | 0.81% |
Historical Volatility
HV 10-Day
95.77%
HV 20-Day
138.70%
HV 30-Day
118.55%
HV 60-Day
113.96%
HV Rank
—
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 6/13/2026